C

Co-Diagnostics

CODX

1.13000
USD
-0.03
(-2.59%)
مفتوح الان
حجم التداول
221
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
40,846,083
أصول ذات صلة
B
BIOC
-0.09610
(-18.27%)
0.42990 USD
C
CEMI
0.02200
(6.47%)
0.35000 USD
D
DGX
5.430
(3.81%)
147.770 USD
L
LH
18.230
(8.46%)
233.670 USD
O
OPK
-0.05000
(-3.50%)
1.38000 USD
O
OSUR
0.01000
(0.22%)
4.50000 USD
Q
QDEL
2.700
(6.88%)
41.950 USD
TMO
9.03
(1.47%)
621.78 USD
الأخبار المقالات

العنوان: Co/Diagnostics

القطاع: Healthcare
الصناعة: Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.